These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25446397)

  • 1. GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases.
    Fujita Y; Ito M; Kojima T; Yatsuga S; Koga Y; Tanaka M
    Mitochondrion; 2015 Jan; 20():34-42. PubMed ID: 25446397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers and clinical rating scales for sodium pyruvate therapy in patients with mitochondrial disease.
    Koga Y; Povalko N; Inoue E; Nashiki K; Tanaka M
    Mitochondrion; 2019 Sep; 48():11-15. PubMed ID: 30738201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic profiling rationalized pyruvate efficacy in cybrid cells harboring MELAS mitochondrial DNA mutations.
    Kami K; Fujita Y; Igarashi S; Koike S; Sugawara S; Ikeda S; Sato N; Ito M; Tanaka M; Tomita M; Soga T
    Mitochondrion; 2012 Nov; 12(6):644-53. PubMed ID: 22884939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of pyruvate therapy for mitochondrial diseases.
    Tanaka M; Nishigaki Y; Fuku N; Ibi T; Sahashi K; Koga Y
    Mitochondrion; 2007 Dec; 7(6):399-401. PubMed ID: 17881297
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of pyruvate therapy in patients with mitochondrial disease: a semi-quantitative clinical evaluation study.
    Fujii T; Nozaki F; Saito K; Hayashi A; Nishigaki Y; Murayama K; Tanaka M; Koga Y; Hiejima I; Kumada T
    Mol Genet Metab; 2014 Jun; 112(2):133-8. PubMed ID: 24830361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Glycemic Control Decreases the Elevated Serum FGF21 Level without Affecting Normal Serum GDF15 Levels in a Patient with Mitochondrial Diabetes.
    Murakami T; Ueba Y; Shinoto Y; Koga Y; Kaneda D; Hatoko T; Kato T; Yonemitsu S; Muro S; Oki S
    Tohoku J Exp Med; 2016 Jun; 239(2):89-94. PubMed ID: 27212224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyruvate therapy for mitochondrial DNA depletion syndrome.
    Saito K; Kimura N; Oda N; Shimomura H; Kumada T; Miyajima T; Murayama K; Tanaka M; Fujii T
    Biochim Biophys Acta; 2012 May; 1820(5):632-6. PubMed ID: 21855607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyruvate Improved Insulin Secretion Status in a Mitochondrial Diabetes Mellitus Patient.
    Inoue T; Murakami N; Ayabe T; Oto Y; Nishino I; Goto Y; Koga Y; Sakuta R
    J Clin Endocrinol Metab; 2016 May; 101(5):1924-6. PubMed ID: 26885883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders.
    Yatsuga S; Fujita Y; Ishii A; Fukumoto Y; Arahata H; Kakuma T; Kojima T; Ito M; Tanaka M; Saiki R; Koga Y
    Ann Neurol; 2015 Nov; 78(5):814-23. PubMed ID: 26463265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood biomarkers of mitochondrial disease-One for all or all for one?
    Suomalainen A
    Handb Clin Neurol; 2023; 194():251-257. PubMed ID: 36813317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new diagnostic indication device of a biomarker growth differentiation factor 15 for mitochondrial diseases: From laboratory to automated inspection.
    Koga Y; Povalko N; Inoue E; Ishii A; Fujii K; Fujii T; Murayama K; Mogami Y; Hata I; Ikawa M; Fukami K; Fukumoto Y; Nomura M; Ichikawa K; Yoshida K
    J Inherit Metab Dis; 2021 Mar; 44(2):358-366. PubMed ID: 32965044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age-related disorders.
    Fujita Y; Taniguchi Y; Shinkai S; Tanaka M; Ito M
    Geriatr Gerontol Int; 2016 Mar; 16 Suppl 1():17-29. PubMed ID: 27018280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF21 outperforms GDF15 as a diagnostic biomarker of mitochondrial disease in children.
    Riley LG; Nafisinia M; Menezes MJ; Nambiar R; Williams A; Barnes EH; Selvanathan A; Lichkus K; Bratkovic D; Yaplito-Lee J; Bhattacharya K; Ellaway C; Kava M; Balasubramaniam S; Christodoulou J
    Mol Genet Metab; 2022 Jan; 135(1):63-71. PubMed ID: 34991945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring-sideroblasts.
    Ramirez JM; Schaad O; Durual S; Cossali D; Docquier M; Beris P; Descombes P; Matthes T
    Br J Haematol; 2009 Jan; 144(2):251-62. PubMed ID: 19036111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 21 and grow differentiation factor 15 are sensitive biomarkers of mitochondrial diseases due to mitochondrial transfer-RNA mutations and mitochondrial DNA deletions.
    Formichi P; Cardone N; Taglia I; Cardaioli E; Salvatore S; Gerfo AL; Simoncini C; Montano V; Siciliano G; Mancuso M; Malandrini A; Federico A; Dotti MT
    Neurol Sci; 2020 Dec; 41(12):3653-3662. PubMed ID: 32504279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of serum biomarkers FGF21 and GDF15 compared to muscle sample in mitochondrial disease.
    Lehtonen JM; Auranen M; Darin N; Sofou K; Bindoff L; Hikmat O; Uusimaa J; Vieira P; Tulinius M; Lönnqvist T; de Coo IF; Suomalainen A; Isohanni P
    J Inherit Metab Dis; 2021 Mar; 44(2):469-480. PubMed ID: 32857451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of mitochondrial disorders.
    Shayota BJ
    Neurotherapeutics; 2024 Jan; 21(1):e00325. PubMed ID: 38295557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein biomarkers GDF15 and FGF21 to differentiate mitochondrial hepatopathies from other pediatric liver diseases.
    Van Hove JLK; Friederich MW; Strode DK; Van Hove RA; Miller KR; Sharma R; Shah H; Estrella J; Gabel L; Horslen S; Kohli R; Lovell MA; Miethke AG; Molleston JP; Romero R; Squires JE; Alonso EM; Guthery SL; Kamath BM; Loomes KM; Rosenthal P; Mysore KR; Cavallo LA; Valentino PL; Magee JC; Sundaram SS; Sokol RJ;
    Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38180987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency.
    Finkenstedt A; Bianchi P; Theurl I; Vogel W; Witcher DR; Wroblewski VJ; Murphy AT; Zanella A; Zoller H
    Br J Haematol; 2009 Mar; 144(5):789-93. PubMed ID: 19120353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease.
    Davis RL; Liang C; Edema-Hildebrand F; Riley C; Needham M; Sue CM
    Neurology; 2013 Nov; 81(21):1819-26. PubMed ID: 24142477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.